Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: A survey of gynecologists in Belgium

The use of menopause hormone therapy (MHT) has decreased dramatically in all countries since the initial findings of the Women ’s Health Initiative (WHI) were published in 2002 (1). Physicians’ advice and women’s decisions regarding MHT have been clouded by anxiety and confusion for the past decade (2). Moreover, a generation of physicians has not been adequately trained in menopause management (2,3).

Source: Maturitas - August 4, 2019 Category: Primary Care Authors: Serge Rozenberg, Jean Vandromme Source Type: research